Personas / Equipo Humano

F. Xavier Palomer Tarridas

Buscador de publicaciones

Publicaciones

  • Palomer FX, Wang JR, Escalona C, Wu S, Wahli W and Vazquez M.

    Targeting AMPK as a potential treatment for hepatic fibrosis in MASLD.

    TRENDS IN PHARMACOLOGICAL SCIENCES . 46(6): 551-566.

    [doi:10.1016/j.tips.2025.03.008]

  • Irisarri A, Corral A, Perez-Salvador N, Bellver-Sanchis A, Ribalta-Vilella M, Bentanachs R, Alegret M, Laguna JC, Barroso E, Palomer FX, Ortuño-Sahagún D, Vazquez M, Pallàs M, LAURA HERRERO RODRÍGUEZ and Griñán-Ferré C.

    FTO inhibition mitigates high-fat diet-induced metabolic disturbances and cognitive decline in SAMP8 mice

    MOLECULAR MEDICINE . 31(1): 73-73. Nº de citas: 3

    [doi:10.1186/s10020-025-01126-4]

  • Montori M, Barroso E, Jurado-Aguilar J, Peyman M, Wahli W, Palomer FX and Vazquez M.

    Palmitate potentiates the SMAD3-PAI-1 pathway by reducing nuclear GDF15 levels

    CELLULAR AND MOLECULAR LIFE SCIENCES . 82(1): 43-43.

    [doi:10.1007/s00018-024-05571-y]

  • Wang JR, Jurado-Aguilar J, Barroso E, Rodríguez-Calvo R, Camins A, Wahli W, Palomer FX and Vazquez M.

    PPARß/d upregulates the insulin receptor ß subunit in skeletal muscle by reducing lysosomal activity and EphB4 levels.

    CELL COMMUNICATION AND SIGNALING . 22(1): 595-595.

    [doi:10.1186/s12964-024-01972-5]

  • Rostami A, Palomer FX, Pizarro J, Barroso E, Valenzuela-Alcaraz BI, Crispi F, Nistal JF, Hurlé MA, García R, Wahli W and Vazquez M.

    PPARß/d prevents inflammation and fibrosis during diabetic cardiomyopathy

    PHARMACOLOGICAL RESEARCH . 210: 107515-107515. Nº de citas: 1

    [doi:10.1016/j.phrs.2024.107515]

  • Barroso E, Jurado-Aguilar J, Wahli W, Palomer FX and Vazquez M.

    Increased hepatic gluconeogenesis and type 2 diabetes mellitus

    TRENDS IN ENDOCRINOLOGY AND METABOLISM . 35(12): 1062-1077. Nº de citas: 11

    [doi:10.1016/j.tem.2024.05.006]

  • Zhang M, Barroso E, Peña L, Rada P, Valverde ÁM, Wahli W, Palomer FX and Vazquez M.

    PPARß/d attenuates hepatic fibrosis by reducing SMAD3 phosphorylation and p300 levels via AMPK in hepatic stellate cells

    Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie . 179: 117303-117303. Nº de citas: 6

    [doi:10.1016/j.biopha.2024.117303]

  • Palomer FX, Salvador JM, Griñán-Ferré C, Barroso E, Pallàs M and Vazquez M.

    GADD45A: With or without you

    MEDICINAL RESEARCH REVIEWS . 44(4): 1375-1403. Nº de citas: 18

    [doi:10.1002/med.22015]

  • Peyman M, Babin-Ebell A, Rodríguez-Rodríguez R, Rigon M, Aguilar-Recarte D, Villarroya-Terrade J, Planavila A, Villarroya-Gombau F, Palomer FX, Barroso E and Vazquez M.

    SIRT1 regulates hepatic vldlr levels

    CELL COMMUNICATION AND SIGNALING . 22(1): 297-297. Nº de citas: 3

    [doi:10.1186/s12964-024-01666-y]

  • Griñán-Ferré C, Jarne-Ferrer J, Bellver-Sanchis A, Ribalta-Vilella M, Barroso E, Salvador JM, Jurado-Aguilar J, Palomer FX, Vazquez M and Pallàs M.

    Deletion of Gadd45a Expression in Mice Leads to Cognitive and Synaptic Impairment Associated with Alzheimer's Disease Hallmarks

    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES . 25(5): . Nº de citas: 2

    [doi:10.3390/ijms25052595]